Diagnostic Testing & Technology Report

On July 24, molecular diagnostics company AutoGenomics (Carlsbad, Calif.) filed papers with the Securities and Exchange Commission (SEC) for an initial public offering worth up to $86.3 million. The company, which intends to reincorporate in Delaware after the IPO, plans to list its shares on the Nasdaq under the symbol AGMX.